In NAFLD animal models, SREBP-1c mRNA and its active nuclear protein form are increased, demonstrating that SREBP-1c overexpression leads to lipid accumulation in the liver [12]. The gene discussed is SREBF1; the disease is metabolic dysfunction-associated steatotic liver disease.